{"id":49883,"date":"2022-10-20T20:01:50","date_gmt":"2022-10-20T18:01:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/"},"modified":"2022-10-20T20:01:50","modified_gmt":"2022-10-20T18:01:50","slug":"biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/","title":{"rendered":"BioGX Announces Availability of Xfree PCR Reagents for Monkeypox"},"content":{"rendered":"
\n

BIRMINGHAM, Ala.–(BUSINESS WIRE)–#PCR<\/a>–To address the growing need for simplified, rapid testing for Monkeypox, BioGX, a global provider of easy molecular diagnostic solutions, announced availability of Xfree PCR reagents for Sample-to-Answer Direct Sample PCR on multiple real-time PCR platforms including BioGX\u2019s rapid \u201cpixl\u201d platform.\n<\/p>\n

<\/a><\/p>\n

\nDr. Suzane Silbert, Director, Esoteric Testing\/R&D and Microbiology Laboratories at Tampa General Hospital (TGH) said, \u201cWe validated the BioGX Xfree hMPXV\/OPXV custom manufactured reagents as Laboratory Developed Test on two platforms, BioGX\u2019s pixl real-time PCR instrument and another Sample-to-answer Open System platform. The test is robust and showed excellent performance on both platforms with pixl having an advantage of a small footprint and providing 3x faster results.\u201d She further added, \u201cPrior to sourcing the reagents from BioGX, TGH was sending tests to an external reference laboratory with much longer turnaround time and higher costs.\u201d\n<\/p>\n

\n\u201cBioGX Monkeypox Xfree PCR reagents validated by TGH leverages the highly successful Xfree<\/i> extraction-free direct sample testing chemistry that is also included in the BioGX EUA Xfree<\/i> COVID-19 Direct RT-PCR test,\u201d said Robert Martinez, Ph.D., Sr. Director of Scientific Affairs & Strategic Partnerships. He further noted, \u201cBioGX Monkeypox reagents incorporate the US CDC primer\/probe designs to detect West African and Central African (Congo Basin) clades of the Monkeypox virus, and separately screen for non-variola Orthopox viruses.\u201d\n<\/p>\n

\nBioGX\u2019s Xfree Direct Sample PCR reagents offer the flexibility to validate testing using a direct swab collection at point-of-care or a swab sample collected in transport media such as Copan UTM\u00ae<\/sup>, Copan ESwab\u2122<\/sup>, Viral Transport Media or Phosphate Buffered Saline, completely bypassing the need for additional equipment and consumables for sample processing and extraction, saving both time and money.\n<\/p>\n

\nPlease contact BioGX Sales (phone: 205-250-8055 or email: sales@biogx.com<\/a>) if interested in implementing the test in your testing facility.\n<\/p>\n

\nAbout BioGX<\/b>\n<\/p>\n

\nBioGX is a leading global provider of lyophilized real-time PCR reagents for molecular diagnostics. BioGX, Inc., headquartered in Birmingham, Alabama and Dallas, TX, and its wholly owned subsidiary BioGX B.V., based in Amsterdam, The Netherlands, (collectively \u201cBioGX\u201d), operates in a cGMP compliant environment certified to ISO 13485 medical device development and manufacturing standards. The proprietary Sample-Ready\u2122<\/sup> technology is at the core of all product offerings for Clinical, Food Safety, Pharma QC and Water Quality molecular testing. BioGX\u2019s 60+ multiplex real-time PCR products are marketed and sold worldwide through its Global Distribution Network.\n<\/p>\n

\nFor more information on BioGX, please visit BioGX.com<\/a>.\n<\/p>\n

\nSample-Ready, Just Add Water and Xfree<\/i> are trademarks of BioGX, Inc.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMohammed Merchant
\n
Sr. Director, Digital Marketing
\n
+1.205.250.8055
\n
marketing@biogx.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BIRMINGHAM, Ala.–(BUSINESS WIRE)–#PCR–To address the growing need for simplified, rapid testing for Monkeypox, BioGX, a global provider of easy molecular diagnostic solutions, announced availability of Xfree PCR reagents for Sample-to-Answer Direct Sample PCR on multiple real-time PCR platforms including BioGX\u2019s rapid \u201cpixl\u201d platform. Dr. Suzane Silbert, Director, Esoteric Testing\/R&D and Microbiology Laboratories at Tampa General … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-49883","format-standard","category-industry"],"yoast_head":"\nBioGX Announces Availability of Xfree PCR Reagents for Monkeypox - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioGX Announces Availability of Xfree PCR Reagents for Monkeypox - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BIRMINGHAM, Ala.–(BUSINESS WIRE)–#PCR–To address the growing need for simplified, rapid testing for Monkeypox, BioGX, a global provider of easy molecular diagnostic solutions, announced availability of Xfree PCR reagents for Sample-to-Answer Direct Sample PCR on multiple real-time PCR platforms including BioGX\u2019s rapid \u201cpixl\u201d platform. Dr. Suzane Silbert, Director, Esoteric Testing\/R&D and Microbiology Laboratories at Tampa General ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-20T18:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221020005913\/en\/1609200\/21\/BioGX_Logo_-_transparent_background.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"BioGX Announces Availability of Xfree PCR Reagents for Monkeypox\",\"datePublished\":\"2022-10-20T18:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/\"},\"wordCount\":440,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005913\\\/en\\\/1609200\\\/21\\\/BioGX_Logo_-_transparent_background.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/\",\"name\":\"BioGX Announces Availability of Xfree PCR Reagents for Monkeypox - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005913\\\/en\\\/1609200\\\/21\\\/BioGX_Logo_-_transparent_background.jpg\",\"datePublished\":\"2022-10-20T18:01:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005913\\\/en\\\/1609200\\\/21\\\/BioGX_Logo_-_transparent_background.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221020005913\\\/en\\\/1609200\\\/21\\\/BioGX_Logo_-_transparent_background.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioGX Announces Availability of Xfree PCR Reagents for Monkeypox\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioGX Announces Availability of Xfree PCR Reagents for Monkeypox - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/","og_locale":"en_US","og_type":"article","og_title":"BioGX Announces Availability of Xfree PCR Reagents for Monkeypox - Pharma Trend","og_description":"BIRMINGHAM, Ala.–(BUSINESS WIRE)–#PCR–To address the growing need for simplified, rapid testing for Monkeypox, BioGX, a global provider of easy molecular diagnostic solutions, announced availability of Xfree PCR reagents for Sample-to-Answer Direct Sample PCR on multiple real-time PCR platforms including BioGX\u2019s rapid \u201cpixl\u201d platform. Dr. Suzane Silbert, Director, Esoteric Testing\/R&D and Microbiology Laboratories at Tampa General ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-20T18:01:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221020005913\/en\/1609200\/21\/BioGX_Logo_-_transparent_background.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"BioGX Announces Availability of Xfree PCR Reagents for Monkeypox","datePublished":"2022-10-20T18:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/"},"wordCount":440,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221020005913\/en\/1609200\/21\/BioGX_Logo_-_transparent_background.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/","url":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/","name":"BioGX Announces Availability of Xfree PCR Reagents for Monkeypox - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221020005913\/en\/1609200\/21\/BioGX_Logo_-_transparent_background.jpg","datePublished":"2022-10-20T18:01:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221020005913\/en\/1609200\/21\/BioGX_Logo_-_transparent_background.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221020005913\/en\/1609200\/21\/BioGX_Logo_-_transparent_background.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/biogx-announces-availability-of-xfree-pcr-reagents-for-monkeypox\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"BioGX Announces Availability of Xfree PCR Reagents for Monkeypox"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49883"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49883\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}